Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07BMA
|
||||
| Former ID |
DNC005995
|
||||
| Drug Name |
Bbs-Arg-(D-Pip)-Gly-S-(GS)5-Gly-Hir
|
||||
| Indication | Discovery agent | Investigative | [527780] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C118H174N30O47S
|
||||
| Canonical SMILES |
CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C<br />(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)<br />C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC<br />=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C<br />(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(<br />CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C4CCCCN4C(=O)C(CCCN=C<br />(N)N)NS(=O)(=O)C5=CC=C(C=C5)C(C)(C)C
|
||||
| InChI |
1S/C118H174N30O47S/c1-8-60(4)97(115(191)148-41-15-20-83(148)113(189)140-68(32-37-94(168)169)105(181)137-67(31-36-93(166)167)106(182)143-74(44-62-21-25-64(155)26-22-62)110(186)142-72(42-59(2)3)108(184)141-71(116(192)193)29-34-84(119)156)145-107(183)69(33-38-95(170)171)138-104(180)66(30-35-92(164)165)139-109(185)73(43-61-16-10-9-11-17-61)144-111(187)75(45-96(172)173)130-85(157)46-123-98(174)76(53-149)131-86(158)47-124-99(175)77(54-150)132-87(159)48-125-100(176)78(55-151)133-88(160)49-126-101(177)79(56-152)134-89(161)50-127-102(178)80(57-153)135-90(162)51-128-103(179)81(58-154)136-91(163)52-129-112(188)82-19-12-13-40-147(82)114(190)70(18-14-39-122-117(120)121)146-196(194,195)65-27-23-63(24-28-65)118(5,6)7/h9-11,16-17,21-28,59-60,66-83,97,146,149-155H,8,12-15,18-20,29-58H2,1-7H3,(H2,119,156)(H,123,174)(H,124,175)(H,125,176)(H,126,177)(H,127,178)(H,128,179)(H,129,188)(H,130,157)(H,131,158)(H,132,159)(H,133,160)(H,134,161)(H,135,162)(H,136,163)(H,137,181)(H,138,180)(H,139,185)(H,140,189)(H,141,184)(H,142,186)(H,143,182)(H,144,187)(H,145,183)(H,164,165)(H,166,167)(H,168,169)(H,170,171)(H,172,173)(H,192,193)(H4,120,121,122)/t60-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82?,83-,97-/m0/s1
|
||||
| InChIKey |
PUATYUGHSGBOAZ-BSPCXEMDSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Coagulation factor IIa | Target Info | Inhibitor | [527780] | |
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Blood coagulation | ||||
| PathWhiz Pathway | Vitamin K Metabolism | ||||
| Coagulation | |||||
| Reactome | Intrinsic Pathway of Fibrin Clot Formation | ||||
| Common Pathway of Fibrin Clot Formation | |||||
| Gamma-carboxylation of protein precursors | |||||
| Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | |||||
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | |||||
| Cell surface interactions at the vascular wall | |||||
| Peptide ligand-binding receptors | |||||
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | |||||
| G alpha (q) signalling events | |||||
| Thrombin signalling through proteinase activated receptors (PARs) | |||||
| WikiPathways | Complement and Coagulation Cascades | ||||
| Regulation of Actin Cytoskeleton | |||||
| IL1 and megakaryotyces in obesity | |||||
| Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | |||||
| PTM: gamma carboxylation, hypusine formation and arylsulfatase activation | |||||
| Blood Clotting Cascade | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| Thrombin signalling through proteinase activated receptors (PARs) | |||||
| Platelet Aggregation (Plug Formation) | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| Formation of Fibrin Clot (Clotting Cascade) | |||||
| Cell surface interactions at the vascular wall | |||||
| Folate Metabolism | |||||
| Vitamin B12 Metabolism | |||||
| Selenium Micronutrient Network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.